Cannabis Law Report

SEPTEMBER 23, 2022

Bill sponsor Senator Scott Wiener, who enlisted MAPS to advise on the bill, led the reform closer to passage than any previous state-wide psychedelic decriminalization legislation. On the heels of the update about SB 519 was news of Governor Gavin Newsom vetoing another proposed piece of drug policy legislation sponsored by Senator Wiener.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. See Deborah Brauser, FDA Permits Psilocybin to Be Tested for Refractory Depression, MEDSCAPE (Oct.

Law 105

Law Therapy Clinical Trials Research and Development 105

The Blunt Truth

AUGUST 13, 2019

In March of 2019, the FDA established a Working Group to determine the possible legislative pathways to regulate CBD. Specifically, the group aims to “make recommendations” on CBD legislation to Congress. The public hearing attracted over 100 speakers and 2000 participants. Under section 331(ll) of the FD&C Act (21 U.S.C.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

The Cannigma

JULY 1, 2022

Preclinical studies involve exposing cells and animals to treatments to see if there are indications that the treatment could be worth evaluating in humans. Clinical studies are performed in people and can be controlled in various ways to understand how people respond to a treatment.

Research and Development 108

Research and Development Data THC Clinical Trials 108

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JULY 23, 2019

Therefore, on 31 December 2018 the commission sent a legislative report to Maryland’s General Assembly that laid the groundwork for several bills submitted during the 2019 legislative session. There is no uniform set of state laws for marketing legal cannabis at this time. a playground, recreation centre, library or public park.

Law 40

Law Clinical Trials CBD Edibles 40

The Joint Blog

APRIL 17, 2020

And with the legalization of cannabis in Canada and legislation in 33 US states allowing for some kind of marijuana use (recreational or medicinal), the popularity of cannabis has been on the rise. Diminishing efficacy of these receptors over time should be considered for proper treatment.

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

DECEMBER 9, 2021

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec. DENVER, Dec.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

SEPTEMBER 3, 2019

Federal legislation to enable the production and sale of cannabis for medical use and related research purposes was passed by Australia’s parliament in 2016. The laws allow concentrate-based medical cannabis to be prescribed in Australia for the treatment of a variety of specific illnesses. Australian Leadership Appointments.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. Last week in Nature Medicine , I.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

CannaMD

MARCH 8, 2021

Read on to learn why CannaMD is leading the charge with other physician groups to educate legislators and oppose H.B. Prohibiting a medical marijuana treatment center from dispensing marijuana that exceeds a certain potency of tetrahydrocannabinol [p. 1455 – and how YOU can fight back with research-based arguments! 2, line 32].

THC 116

THC Research and Development Treatment Patients 116

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Advance to FDA IND-enabling studies to support human clinical studies. Previously the Company announced that it had secured FDA Orphan Drug Designation for cepharanthine in the treatment of esophageal cancer.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

The Cannigma

MAY 6, 2021

Other than serving as a lighter version of delta-9-THC, delta-8 has also been researched as a potential treatment for a number of medical conditions and symptoms such as vomiting and nausea, glaucoma, pain, and inflammation. When it comes to safety, the two main factors to consider are production (standards and regulation) and research.

THC 145

THC Cannabinoids Concentrates Hemp 145

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MAY 13, 2019

Mr Gardiner stressed the study – supervised by Professor Lisa Nissen, Head of QUT’s Faculty of Health School of Clinical Sciences – wasn’t about the benefits of medicinal cannabis itself, but how medical professionals reacted to the emerging treatment. Read More & Source: [link]. Gardiner , Judith A. Background.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

The Cannigma

FEBRUARY 1, 2023

To date, very few human clinical trials have been conducted to assess the effectiveness of THC or CBD in treating cancer. 7 The use of cannabis as a cancer treatment was popularized by Rick Simpson, a medical cannabis advocate. GBM is a rare but aggressive brain cancer with very limited treatment options.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Law Report

AUGUST 30, 2019

This is a turnaround from earlier statements Crapo made in opposition to any pro-cannabis legislation. House Judiciary Chairman Jerrod Nadler (D-NY) wrote to NORML members asking for grassroots support for his cannabis legislation, the MORE Act. The SAFE Banking Act (H.R.

Banking 45

Banking Research and Development Legislation Programs 45

The Cannigma

MARCH 12, 2021

And so, they’re trying to standardize, trying to make sure that doctors are are generally coming at problems from a similar perspective, and especially they’re coming at treatments from a similar perspective. And in my belief, it should be cannabis, because of the safety profile, number one.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

JULY 15, 2022

But bottlenecks remain to doctors prescribing the controversial treatment. “Not just the perimeter security, but also the safety and security onsite is paramount.” ADAM BENJAMIN: If I may add to that, and I believe Australia’s not only got the right legislation here, but the best legislation and the best quality.

Medicine 52

Medicine Patients Media Supply Chain 52

The Cannigma

DECEMBER 22, 2021

We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil. It has the – you assume safety, at least to a certain level. I think that they required different legislative actions. We have, I think, eight PhDs. DC: Yes, I agree.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Leaf Science

AUGUST 6, 2019

Some of the businesses and distributors are prohibited from dealing with banks by federal legislation. It is further thought that it will offer tremendous health benefits and add to the safety of athletes. Aurora Cannabis already has 40 clinical trials where they are looking at the effects of cannabis and hemp on the patients.

Research and Development 9

Research and Development Wellness and Beauty Banking CBD 9

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Legislative initiatives (introduction and support of changes of laws). Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

OCTOBER 17, 2019

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. Cannabis has been legal for medical purposes in Canada since 2001, with several iterations of regulation and legislation shaping the industry over the years.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

JANUARY 28, 2019

The good news for Kentucky legislators is the data already i s available. The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. The discussion must progress beyond verbal jabs and dismissiveness. 8 – state Rep.

Data 187

Data Clinical Trials Chronic Pain Medicine 187

Cannabis Law Report

JANUARY 14, 2020

Legislation. Additionally, it would open up medical marijuana policies with “directives to conduct research on the impact of marijuana on the brain, the efficacy of medical marijuana, identification of additional medical benefits and uses of cannabis, and support highway safety research.”. CLICK IMAGE TO ACCESS COMMITTEE INFO PAGE.

Clinical Trials 69

Clinical Trials Programs Access DEA 69